Monopar Therapeutics (MNPR) Director Kim Tsuchimoto Sells $455,566

Kim Tsuchimoto, a director at Monopar Therapeutics (MNPR), sold shares worth $455,566. This transaction may affect stock perceptions as it involves significant amounts. The timing and reasoning behind the sale could influence market sentiment. Investors often watch insider transactions like this to gauge future company performance or insider confidence in the firm.